Research & development > Clinical diagnostics

Retinal damage a marker of MS severity

17 August, 2022

Retinal layer thinning as a result of an MS relapse can predict the severity of future relapses and, hence, the likelihood of disability.


Bacteria in saliva may indicate PTSD in veteran soldiers

16 August, 2022

Researchers have found that people with PTSD and high psychopathological indications exhibit the same picture of bacteria in the saliva (a unique oral microbiotic signature).


Peptide 'fingerprint' enables earlier Alzheimer's diagnosis

04 August, 2022

Researchers created a method for detecting folding errors at early stages of neurodegenerative diseases, via the structure of dried protein and peptide solutions.


Pfizer to acquire ResApp, developer of smartphone COVID test

14 April, 2022

ResApp Health has developed a novel cough audio-based COVID-19 screening test that only requires a smartphone.


Hypertension patients should be tested for primary aldosteronism

30 March, 2022

A simple blood test for the adrenal disease known as primary aldosteronism could save hypertension patients from unnecessary illness, medication and expense.


ATP sensor helps to monitor disease severity

04 March, 2022

Scientists have designed a prototype biosensor that detects levels of adenosine triphosphate (ATP) and lactates in a patient's blood.


Blood tests may enable early ALS diagnosis

08 February, 2022

These tests would involve measuring the blood level of a substance that varies in concentration depending on which variant of ALS the patient has.


Diagnostic test for schistosomiasis on the horizon

01 December, 2021

To interrupt the spread of the disease, a test needs to be sensitive enough to identify people with low-level infections.


Blood tests predict chemo resistance in prostate cancer patients

22 November, 2021

The findings could enable doctors to detect early on if a treatment is working and switch to alternatives such as abiraterone or cabazitaxel if it is not.


A urine test for intermediate-risk prostate cancer

08 November, 2021

A prostate cancer urine test can identify men at intermediate risk of aggressive disease, who can safely avoid immediate treatment.


Saliva testing may allow early detection of HPV-driven cancers

21 October, 2021

Researchers investigated the efficacy of salivary HPV detection as a biomarker of HPV-driven head and neck cancers.


No more liver biopsies for haemochromatosis patients?

30 August, 2021

Liver damage caused by a life-threatening genetic blood disorder, known as hereditary haemochromatosis, can be detected with a simple blood test or scan.


Test to better detect early-stage ovarian cancer

30 July, 2021

A new test could help reduce the high mortality rate from ovarian cancer by dramatically improving the accuracy of early detection.


One-hour Hendra test developed for horses

23 July, 2021

Vets have developed a diagnostic point-of-care kit that is claimed to detect the deadly Hendra virus in horses faster than ever — in under an hour, rather than days.


Blood test could help diagnose frontotemporal dementia

16 July, 2021

Blood-based measurement of glial fibrillary acidic protein (GFAP) can distinguish patients with frontotemporal dementia from those with primary psychiatric disorders or healthy individuals.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd